NABPACLIEVA 100 MG Injection (Nab-Paclitaxel): Advanced Albumin-Bound Nanotechnology in Oncology NABPACLIEVA 100 MG Injection represents a significant technological leap in chemotherapy, featuring the active pharmaceutical ingredient Nab-Paclitaxel (Nanoparticle Albumin-Bound Paclitaxel). Unlike traditional paclitaxel, which requires solvent-based delivery, NABPACLIEVA utilizes cutting-edge nanotechnology to bind paclitaxel to human albumin. This specialized delivery system enhances the drug's solubility, improves its safety profile, and allows for higher doses to be delivered directly to the tumor microenvironment. Therapeutic Indications and Global Usage Metastatic Breast Cancer: Indicated for patients who have failed prior chemotherapy for metastatic disease or have experienced a relapse within six months of adjuvant chemotherapy. Non-Small Cell Lung Cancer (NSCLC): Used as a first-line treatment in combination with carboplatin for patients with locally advanced or metastatic NSCLC who are not candidates for curative surgery or radiation. Metastatic Adenocarcinoma of the Pancreas: Often used as a first-line treatment in combination with gemcitabine to improve survival outcomes. Advanced Ovarian Cancer: Frequently utilized in specialized treatment cycles where solvent-free paclitaxel is preferred. The Mechanism: Nanoparticle Albumin-Bound (nab) Technology Albumin-Mediated Transport: Cancer cells often overexpress SPARC (Secreted Protein Acidic and Rich in Cysteine), a protein that binds to albumin. NABPACLIEVA exploits this biological pathway to “pull“ the chemotherapy directly into the tumor. Solvent-Free Delivery: Traditional paclitaxel uses Cremophor EL, which often causes severe allergic reactions. NABPACLIEVA is solvent-free, significantly reducing the risk of infusion-related hypersensitivity.Enhanced Penetration: The nanoparticles (approximately 130 nanometers) facilitate better penetration through the endothelial cell wall and into the tumor tissue. Microtubule Inhibition: Once inside the cell, it works by stabilizing microtubules, preventing the cancer cell from dividing and eventually inducing apoptosis (cell death). Dosage and Administration Guidelines Route: Administered solely via Intravenous (IV) Infusion. Standard Regimen: Typically administered over 30 minutes, which is significantly faster than the 3-hour infusion required for standard paclitaxel. Cycle Frequency: Depending on the indication, it is often administered on Days 1, 8, and 15 of a 21-day or 28-day cycle. Dose Modifications: Oncologists may adjust the 100mg dosage based on the patient's body surface area (BSA) and hematological tolerance. Safety Profile and Clinical Monitoring Myelosuppression: Regular monitoring of Complete Blood Counts (CBC) is essential to manage potential neutropenia (low white blood cell count). Peripheral Neuropathy: Checking for sensory disturbances such as tingling or numbness in the hands and feet. Hepatic Health: Periodic liver function tests (LFTs) are mandatory for safety and efficacy. Fatigue & Gastrointestinal Effects: Managing common side effects like tiredness, nausea, and mild joint pain. Storage and Global Handling Storage: Store the un-reconstituted vial at room temperature (20°C to 25°C) in the original carton to protect it from light. Reconstitution: Once reconstituted, the suspension should be used within the clinical stability window defined by the manufacturer. Why Choose Ernest Oncology? 100% Genuine Supply: We source products directly from GMP-certified channels, ensuring every vial is authentic with an optimal shelf life. Verified Export Network: We facilitate rapid and secure shipping to the USA, UK, UAE, Australia, Singapore, South Africa, Europe, Middle East, Africa, and Asia. Cold Chain & Specialized Logistics: Our team manages pharmaceutical exports with precision, ensuring the integrity of the nanoparticle formulation during international transit. Regulatory & Documentation Excellence: We handle all necessary export paperwork, including Certificates of Analysis (CoA) and permits, for seamless customs clearance. Bulk Supplier Advantage: As a dedicated distributor, we offer competitive wholesale rates to support oncology hospitals, clinics, and government health programs. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct WhatsApp Connection
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us